12/7/2012

A study in the Journal of the American College of Cardiology found higher-dose atorvastatin was associated with an increased risk of new-onset diabetes compared with lower-dose treatment. However, the risk only appeared to be higher in patients with at least two risk factors for increased blood glucose levels, compared with those who only had one risk factor.

Related Summaries